Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment
Leukemia
.
2024 Aug;38(8):1863.
doi: 10.1038/s41375-024-02307-6.
Authors
Jean-Sébastien Claveau
1
,
David L Murray
1
2
,
Angela Dispenzieri
1
,
Prashant Kapoor
1
,
Moritz Binder
1
,
Francis Buadi
1
,
David Dingli
1
,
Amie Fonder
1
,
Morie Gertz
1
,
Wilson Gonsalves
1
,
Suzanne Hayman
1
,
Miriam Hobbs
1
,
Yi Lisa Hwa
1
,
Taxiarchis Kourelis
1
,
Martha Lacy
1
,
Nelson Leung
1
,
Yi Lin
1
,
Rahma Warsame
1
,
Robert A Kyle
1
,
Vincent Rajkumar
1
,
Shaji K Kumar
3
Affiliations
1
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
2
Department of Laboratory, Mayo Clinic, Rochester, MN, USA.
3
Division of Hematology, Mayo Clinic, Rochester, MN, USA. Kumar.Shaji@mayo.edu.
PMID:
38886490
DOI:
10.1038/s41375-024-02307-6
No abstract available
Publication types
Published Erratum